11/6/2013 9:25:12 AM
BERKELEY HEIGHTS, N.J., Nov. 6, 2013 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) (Cyclacel or the Company), a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders will announce third quarter 2013 financial results on Tuesday, November 12, 2013. The Company will host a conference call and live webcast at 4:30 pm Eastern time on the same day.
Help employers find you! Check out all the jobs and post your resume.
comments powered by